from Raymond James issued a price target of $54.00 for NGS on 2026-07-10 12:49:53.The adjusted price target was set to $54.00.At the time of the announcement, NGS...
from Hovde Group issued a price target of $24.00 for CZWI on 2026-07-10 11:39:26.The adjusted price target was set to $24.00.At the time of the announcement, CZWI...
from Wells Fargo issued a price target of $11.00 for XFOR on 2026-07-10 10:22:06.The adjusted price target was set to $11.00.At the time of the announcement, XFOR...
from BTIG issued a price target of $9.00 for TOI on 2026-07-09 16:43:00.The adjusted price target was set to $9.00.At the time of the announcement, TOI was...
from Oppenheimer issued a price target of $8.00 for CNTB on 2026-07-09 11:57:01.The adjusted price target was set to $8.00.At the time of the announcement, CNTB was...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...